ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS
申请人:Oncoarendi Therapeutics SA
公开号:EP3452485A2
公开(公告)日:2019-03-13
1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
申请人:Eli Lilly and Company
公开号:US20170233378A1
公开(公告)日:2017-08-17
1-Oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors.
[EN] ARGINASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS<br/>[FR] INHIBITEURS D'ARGINASE ET LEURS APPLICATIONS THÉRAPEUTIQUES
申请人:ONCOARENDI THERAPEUTICS SA
公开号:WO2017191130A2
公开(公告)日:2017-11-09
Disclosed are small molecule therapeutic compounds that are potent inhibitors of arginase 1 and arginase 2 activity. Also disclosed are pharmaceutical compositions comprising the compounds, and methods for using the compounds for treating or preventing a disease or condition associated with arginase activity.